revenue_growth

Nashville, Tenn. – September 11, 2026 -- EvidenceCare has named John Voigt Jr. as its first unified Chief Revenue Officer, consolidating sales and marketing under one executive as the clinical performance improvement platform enters its next growth phase.

Voigt brings a track record of scaling healthcare technology revenue functions

Voigt previously served as executive vice president of growth and strategy at ActiumHealth (Syllable AI), where he led commercial strategy for the company's AI-driven patient access platform. Before that, he directed health system growth strategy at Wellvana Health, building partnerships that generated more than $200 million in annual risk revenue. Earlier in his career, he helped grow Cedar's annual recurring revenue from $2 million to over $85 million.

Gothenburg – – September 07, 2026 -- Zinzino AB reported group revenue of SEK 282.2 million for August 2026, up 15% from SEK 245.9 million a year earlier, as growth in its direct-sales markets offset a sharp decline at subsidiary Faun Pharma.

Sales markets revenue climbs 16% to SEK 280.9 million in August

Zinzino's core direct-sales business generated SEK 280.9 million in August 2026, up from SEK 242.5 million in the same month last year, a 16% increase that drove the bulk of the group's top-line expansion.

Faun Pharma external sales drop to SEK 1.3 million from SEK 3.4 million

Faun Pharma's external sales fell to SEK 1.3 million in August 2026, down from SEK 3.4 million a year earlier, a decline that partially offset the stronger performance of Zinzino's sales markets and reduced the group's overall growth rate to 15% from the 16% posted by the sales markets alone.